Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 8 chart positions in 8 markets.
By chart position
- 🇨🇦CA · Medicine#1535K to 30K
- 🇮🇳IN · Medicine#9510K to 30K
- 🇰🇷KR · Medicine#1351K to 10K
- 🇹🇷TR · Medicine#1430K to 100K
- 🇵🇹PT · Medicine#943K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
15K to 57K🎙 Daily cadence·126 episodes·Last published 5d ago - Monthly Reach
Unique listeners across all episodes (30 days)
51K to 189K🇹🇷53%🇨🇦16%🇮🇳16%+5 more - Active Followers
Loyal subscribers who consistently listen
20K to 76K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Hot Topics: Wellness in Neuro-oncology
May 15, 2026
Unknown duration
Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma
May 11, 2026
Unknown duration
SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology
May 8, 2026
Unknown duration
CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma
May 4, 2026
Unknown duration
Hot Topics: What's next in neuro-oncology
May 1, 2026
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/15/26 | Hot Topics: Wellness in Neuro-oncology | Podcast Host and Interviewee: Venina Kalistratova (host), Nick Gonzalez Castro and Raj Mukherjee (Interviewees) Podcast Description: The Co-chairs of the SNO Wellness Committee discuss wellness and ways to reduce burnout. | — | ||||||
| 5/11/26 | Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma | Host/Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio Description: Shahad Abdulsahib discusses the phase 1/2 BT008NA clinical trial evaluating microbubble-enhanced transcranial focused ultrasound combined with temozolomide in patients with newly diagnosed high-grade glioma, with findings published in The Lancet Oncology in December 2025 | — | ||||||
| 5/8/26 | SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology | Podcast Host and Interviewee: Dr. Shreya Louis (host), Dr. Ryan Cecchi (interviewee) Podcast Description: Dr. Shreya Louis interview Dr. Ryan Cecchi on his career in academic neuropathology focusing on the path to neuro-pathology, interesting developments in the field, and advise for trainees interested in neuro-oncology and neuropathology | — | ||||||
| 5/4/26 | CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma | Podcast Host and Interviewee: Host: Franziska Ippen Interviewee: David Schiff Podcast Description: Dr. Franziska Ippen interviews Dr. David Schiff on his recent manuscript entitled "CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma" | — | ||||||
| 5/1/26 | Hot Topics: What's next in neuro-oncology | Podcast Host and Interviewee: Host: Dr. Dave Rogawski Interviewee: Dr. Fabio Iwamoto Dr. Dave Rogawski interviews Dr. Fabio Iwamoto, incoming Neuro-Oncology Division Chief at Stanford, about where we're headed in neuro-oncology. | — | ||||||
| 4/27/26 | Neuro-Oncology Nugget: Career Development Outreach from SNO✨ | career developmentneuro-oncology+1 | — | SNO | — | career developmentneuro-oncology+3 | — | 3m 11s | |
| 4/24/26 | Neuro-onc Narratives: An Interview with Caroline Catlin✨ | brain tumorart therapy+3 | Caroline Catlin | The New York TimesLongreads+3 | — | brain tumorart+5 | — | 38m 06s | |
| 4/20/26 | Author Interview: "DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma"✨ | IDH-mutant astrocytomaDNA copy number patterns+4 | Bob Jenkins | DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma | — | IDH-mutant astrocytomaDNA copy number+4 | — | 35m 16s | |
| 4/17/26 | Hot Topics: AYA in Neuro-Oncology✨ | adolescent and young adultneuro-oncology+2 | Dr. Mary Jane (MJ) Lim-FatDr. Kee Kiat (Aaron) Yeo | Neuro-Oncology | — | AYAneuro-oncology+4 | — | 31m 43s | |
| 4/13/26 | Neuro-Oncology Nugget: Bivalent EGFR/IL13Rα2 CAR T Cells for Recurrent Glioblastoma✨ | CAR T cellsglioblastoma+3 | Shahad Abdulsahib | bivalent EGFR/IL13Rα2 CAR T cellsNature Medicine | recurrent glioblastoma | CAR T cellsglioblastoma+5 | — | 2m 29s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/10/26 |  SNObound: Career Advice from Dr. Brooke Braman in Radiation Oncology✨ | career adviceradiation oncology+3 | Dr. Brooke Braman | Radiation Oncology | — | radiation oncologycareer advice+3 | — | 23m 04s | |
| 4/6/26 |  Author Interview: Global analysis of clinical trials for children and adolescents with CNS tumors✨ | clinical trialsCNS tumors+3 | Dr. Margit K. MikkelsenDr. Daniel C. Moreira | St. Jude Children's Research HospitalNeuro-Oncology Pediatrics+1 | — | clinical trialsCNS tumors+5 | — | 20m 41s | |
| 3/23/26 | Neuro-Oncology Nugget: Intracerebroventricular B7-H3 CAR T Cells for DIPG✨ | DIPGCAR T cells+3 | Shahad Abdulsahib | Nature Medicineintracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma | — | DIPGB7-H3+4 | — | 2m 52s | |
| 3/20/26 | Neuro-onc Narratives: Advocating for patient well-being in neuro-oncology✨ | patient well-beingneuro-oncology+3 | Dr. Ashlee LoughanDr. Sarah Brahn | Neuro-Oncology | — | neuro-oncologypatient advocacy+3 | — | 42m 50s | |
| 3/16/26 |  Author Interview: Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma✨ | optic pathway low-grade gliomavisual morbidity+3 | Dr. Stefania PicarielloDr. Enrico Opocher | Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma | — | optic pathway gliomavisual morbidity+3 | — | 17m 33s | |
| 3/13/26 | Hot Topics: Clinician-Patient Relationship in Neuro-Oncology | Dr. Dave Rogawski interviews Dr. Akanksha Sharma on how we can optimize the meaningful, longitudinal relationships that drew many of us to the field. | — | ||||||
| 3/9/26 |  Neuro-Oncology Nugget: Targeted Radiotherapy Using Rhenium-186 Nanoliposomes for Recurrent Glioma | Podcast Host and Interviewee: Shahad Abdulsahib, PhD Candidate, UT Health San Antonio Podcast Description: Shahad Abdulsahib discusses a recent Phase 1 clinical trial on Rhenium-186 nanoliposome therapy for recurrent glioma, published in Nature Communications in March 2025. | — | ||||||
| 3/6/26 | SNObound: Career Advice from Dr. Gelareh Zadeh | Dr. Alex Landry interviews Dr. Gelareh Zadeh on her career in academic neurosurgical oncology, focusing on the role of mentorship, how the field has evolved over time, and advice for junior trainees entering the field. | — | ||||||
| 3/2/26 | Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma | Dr. Maya Graham interviews Dr. Lauren Schaff on her manuscript entitled "Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)," published in Neuro-Oncology in January 2026. | — | ||||||
| 2/27/26 | Hot Topics: Radiation Hypofractionation in Glioma | Dr. Nathan Dalton interviews Dr. Joseph Sia on the topic of radiation hypofractionation – its history, current clinical landscape, and potential future developments for patients with gliomas. | — | ||||||
| 2/23/26 | Neuro-Oncology Nugget: Targeting CDK8 in MYC-Driven Medulloblastoma | Shahad Abdulsahib discusses the findings of a recent paper, entitled "Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma", which was published in Nature Communications in December 2025. | — | ||||||
| 2/20/26 | Neuro-Onc Narratives: Patient Services at the American Brain Tumor Association | Dr. Rachna Malani interviews Mindy Freund about her work at the American Brain Tumor Association | — | ||||||
| 2/16/26 | Author Interview: Post-irradiation chemotherapy in patients with newly diagnosed ependymoma | Dr. Jasmin Jo interviews Dr. Amy Smith and Dr. David Ellison on their manuscript, entitled "Phase 3 randomized trial of post-irradiation chemotherapy in patients with newly diagnosed ependymoma, a report from the Children's Oncology Group" published in Neuro-Oncology in December 2025. | — | ||||||
| 2/13/26 | Hot Topics: How longitudinal profiling of glioma informs therapy development | Dr. Dave Rogawski interviews Dr. David Solomon on his research that sheds light on how key genomic alterations in high-grade glioma evolve over time and how these insights might inform therapeutic development. | — | ||||||
| 2/9/26 | Neuro-oncology Nugget: Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma | Dr. Haseeb Mehmood discusses the use of microbubble-enhanced transcranial focused ultrasound combined with standard temozolomide in high-grade glioma. | — | ||||||
Showing 25 of 136
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
9 placements across 8 markets.
Chart Positions
9 placements across 8 markets.